Login Register Cart 0
Generic placeholder image

Letters in Drug Design & Discovery

Editor-in-Chief

ISSN (Print): 1570-1808
ISSN (Online): 1875-628X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Synthesis and Cytotoxicity of New Mannich Bases of 6-[3-(3,4,5-Trimetoxyphenyl)-2- propenoyl]-2(3H)-Benzoxazolone

Author(s): Ognyan Ivanov Petrov, Yordanka Borisova Ivanova*, Mariana Stefanova Gerova and Georgi Tsvetanov Momekov

Volume 17, Issue 4, 2020

Page: [512 - 517] Pages: 6

DOI: 10.2174/1570180816666190730164952

Abstract

Background: Chemotherapy is one of the mainstays of cancer treatment, despite the serious side effects of the clinically available anticancer drugs. In recent years increasing attention has been directed towards novel agents with improved efficacy and selectivity. Compounds with chalcone backbone have been reported to possess various biological activities such as anticancer, antimicrobial, anti-inflammatory, analgesic, antioxidant, etc. It was reported that aminomethylation of hydroxy chalcones to the corresponding Mannich bases increased their cytotoxicity. In this context, our interest has been focused on the design and synthesis of the so-called multi-target molecules, containing two or more pharmacophore fragments.

Methods: A series of Mannich bases were synthesized by the reaction between 6-[3-(3,4,5- trimethoxyphenyl)-2-propenoyl]-2(3Н)-benzoxazolone, formaldehyde, and a secondary amine. The structures of the compounds were confirmed by elemental analysis, IR and NMR spectra. The new Mannich bases were evaluated for their in vitro cytotoxicity against a panel of human tumor cell lines, including BV-173, SKW-3, K-562, HL-60, HD-MY-Z and MDA-MB-231. The effects of selected compounds on the cellular levels of glutathione (GSH) were determined.

Results: The new compounds 4a-e exhibited concentration-dependent cytotoxic effects at micromolar concentrations in MTT-dye reduction assay against a panel of human tumor cell lines, similar to those of starting chalcone 3. The tested agents led to concentration - dependent depletion of cellular GSH levels, whereby the effects of the chalcone prototype 3 and its Mannich base-derivatives were comparable.

Conclusion: The highest chemosensitivity to the tested compounds was observed in BV- 173followed by SKW-3 and HL-60 cell lines.

Keywords: Chalcone, Mannich base, 2(3H)-benzoxazolone, cytotoxicity, oxazole, GSH.

« Previous
Graphical Abstract

[1]
Dimmock, J.R.; Kumar, P. Anticancer and cytotoxic properties of Mannich bases. Curr. Med. Chem., 1997, 4, 1-22.
[2]
Mahapatra, D.K.; Bharti, S.K.; Asati, V. Anti-cancer chalcones: Structural and molecular target perspectives. Eur. J. Med. Chem., 2015, 98, 69-114.
[http://dx.doi.org/10.1016/j.ejmech.2015.05.004] [PMID: 26005917]
[3]
Nowakowska, Z. A review of anti-infective and anti-inflammatory chalcones. Eur. J. Med. Chem., 2007, 42(2), 125-137.
[http://dx.doi.org/10.1016/j.ejmech.2006.09.019] [PMID: 17112640]
[4]
Katsori, A.M.; Hadjipavlou-Litina, D. Recent progress in therapeutic applications of chalcones. Expert Opin. Ther. Pat., 2011, 21(10), 1575-1596.
[http://dx.doi.org/10.1517/13543776.2011.596529] [PMID: 21711087]
[5]
Dimmock, J.R.; Kumar, P.; Quail, J.W.; Pugazhenthi, U.; Yang, J.; Chen, M.; Reid, R.S.; Allen, T.M.; Kao, G.Y.; Cole, S.P.C.; Batist, G.; Balzarini, J.; De Clercq, E. Synthesis and cytotoxic evaluation of some styryl ketones and related compounds. Eur. J. Med. Chem., 1995, 30, 209-217.
[http://dx.doi.org/10.1016/0223-5234(96)88227-4]
[6]
Gul, M.; Atalay, M.; Gul, H.I.; Nakao, C.; Lappalainen, J.; Hänninen, O. The effects of some Mannich bases on heat shock proteins HSC70 and GRP75, and thioredoxin and glutaredoxin levels in Jurkat cells. Toxicol. In Vitro, 2005, 19(5), 573-580.
[http://dx.doi.org/10.1016/j.tiv.2005.03.004] [PMID: 15896550]
[7]
Pati, H.N.; Das, U.; Sharma, R.K.; Dimmock, J.R. Cytotoxic thiol alkylators. Mini Rev. Med. Chem., 2007, 7(2), 131-139.
[http://dx.doi.org/10.2174/138955707779802642] [PMID: 17305587]
[8]
Dimmock, J.R.; Kandepu, N.M.; Hetherington, M.; Quail, J.W.; Pugazhenthi, U.; Sudom, A.M.; Chamankhah, M.; Rose, P.; Pass, E.; Allen, T.M.; Halleran, S.; Szydlowski, J.; Mutus, B.; Tannous, M.; Manavathu, E.K.; Myers, T.G.; De Clercq, E.; Balzarini, J. Cytotoxic activities of Mannich bases of chalcones and related compounds. J. Med. Chem., 1998, 41(7), 1014-1026.
[http://dx.doi.org/10.1021/jm970432t] [PMID: 9544201]
[9]
Gul, H.I.; Yerdelen, K.O.; Gul, M.; Das, U.; Pandit, B.; Li, P.K.; Secen, H.; Sahin, F. Synthesis of 4′-hydroxy-3′-piperidinomethylchalcone derivatives and their cytotoxicity against PC-3 cell lines. Arch. Pharm. (Weinheim), 2007, 340(4), 195-201.
[http://dx.doi.org/10.1002/ardp.200600072] [PMID: 17351963]
[10]
Bilginer, S.; Gul, H.I.; Mete, E.; Das, U.; Sakagami, H.; Umemura, N.; Dimmock, J.R. 1-(3-aminomethyl-4-hydroxyphenyl)-3-pyridinyl-2-propen-1-ones: A novel group of tumour-selective cytotoxins. J. Enzyme Inhib. Med. Chem., 2013, 28(5), 974-980.
[http://dx.doi.org/10.3109/14756366.2012.700927] [PMID: 22803675]
[11]
Yerdelen, K.O.; Gul, H.I.; Sakagami, H.; Umemura, N.; Sukuroglu, M. Synthesis and cytotoxic activities of a curcumin analogue and Its bis- mannich derivatives. Lett. Drug Des. Discov., 2015, 12(8), 643-649.
[http://dx.doi.org/10.2174/1570180812666150213225134]
[12]
Roman, G. Mannich bases in medicinal chemistry and drug design. Eur. J. Med. Chem., 2015, 89, 743-816.
[http://dx.doi.org/10.1016/j.ejmech.2014.10.076] [PMID: 25462280]
[13]
Nepali, K.; Sharma, S.; Sharma, M.; Bedi, P.M.; Dhar, K.L. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids. Eur. J. Med. Chem., 2014, 77, 422-487.
[http://dx.doi.org/10.1016/j.ejmech.2014.03.018] [PMID: 24685980]
[14]
Ivanova, Y.; Momekov, G.; Petrov, O. New heterocyclic chalcones. Part 6. Synthesis and cytotoxic activities of 5- or 6-(3-aryl-2-propenoyl)-2(3H)-benzoxazolones. Heterocycl. Commun., 2013, 19, 23-28.
[http://dx.doi.org/10.1515/hc-2012-0081]
[15]
Ivanova, Y.; Momekov, G.; Petrov, O. Synthesis of Novel Substituted 1,3-diarylpropenone derivatives and their In Vitro Cytotoxic Activity. Lett. Drug Des. Discov., 2009, 6, 353-357.
[http://dx.doi.org/10.2174/1570180810906050353]
[16]
Petrov, O.; Ivanova, Y.; Momekov, G.; Kalcheva, V. New synthetic Chalcones: Cytotoxic mannich bases of 6-(4-Chlorocinnamoyl)-2(3H)-benzoxazolone. Lett. Drug Des. Discov., 2008, 5, 358-362.
[http://dx.doi.org/10.2174/157018008785777342]
[17]
Ivanova, Y.; Momekov, G.; Petrov, O.; Karaivanova, M.; Kalcheva, V. Cytotoxic Mannich bases of 6-(3-aryl-2-propenoyl)-2(3H)-benzoxazolones. Eur. J. Med. Chem., 2007, 42(11-12), 1382-1387.
[http://dx.doi.org/10.1016/j.ejmech.2007.02.019] [PMID: 17459529]
[18]
Bakalova, A.; Buyukliev, R.; Tcholakova, I.; Momekov, G.; Konstantinov, S.; Karaivanova, M. Synthesis, physicochemical investigation and cytotoxic activity of new Pt(II) complexes with hydantoin ligands. Eur. J. Med. Chem., 2003, 38(6), 627-632.
[http://dx.doi.org/10.1016/S0223-5234(03)00080-1] [PMID: 12832135]
[19]
Sedlak, J.; Lindsay, R.H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal. Biochem., 1968, 25(1), 192-205.
[http://dx.doi.org/10.1016/0003-2697(68)90092-4] [PMID: 4973948]
[20]
Bagrij, T.; Klokouzas, A.; Hladky, S.B.; Barrand, M.A. Influences of glutathione on anionic substrate efflux in tumour cells expressing the multidrug resistance-associated protein, MRP1. Biochem. Pharmacol., 2001, 62(2), 199-206.
[http://dx.doi.org/10.1016/S0006-2952(01)00660-8] [PMID: 11389878]
[21]
Awasthi, S.K.; Mishra, N.; Dixit, S.K.; Singh, A.; Yadav, M.; Yadav, S.S.; Rathaur, S. Antifilarial activity of 1,3-diarylpropen-1-one: effect on glutathione-S-transferase, a phase II detoxification enzyme. Am. J. Trop. Med. Hyg., 2009, 80(5), 764-768.
[http://dx.doi.org/10.4269/ajtmh.2009.80.764] [PMID: 19407121]
[22]
Schwöbel, J.A.; Wondrousch, D.; Koleva, Y.K.; Madden, J.C.; Cronin, M.T.; Schüürmann, G. Prediction of michael-type acceptor reactivity toward glutathione. Chem. Res. Toxicol., 2010, 23(10), 1576-1585.
[http://dx.doi.org/10.1021/tx100172x] [PMID: 20882991]
[23]
Avendaño, C.; Menéndez, J. Chapter 4 -Anticancer drugs acting via radical species, photosensitizers and photodynamic therapy of cancer. Medicinal Chemistry of Anticancer Drugs; Elsevier: Amsterdam, 2008, pp. 93-138.
[24]
Kearns, R.; Hall, A. Glutathione and the response of malignant cells to chemotherapy. Drug Discov. Today, 1998, 3(3), 113-121.
[http://dx.doi.org/10.1016/S1359-6446(97)01156-2]

Rights & Permissions Print Cite
Article Metrics
17
© 2024 Bentham Science Publishers | Privacy Policy